Ondansetron use in early pregnancy and the risk of late pregnancy outcomes.

Elizabeth A SuarezKim BoggessStephanie M EngelTil Stürmer Jennifer L LundMichele Jonsson Funk

Published in: Pharmacoepidemiology and drug safety (2020)

Our results do not suggest that ondansetron increases the risk of preterm birth or gestational hypertensive disorders. The weak association observed between ondansetron use and small for gestational age warrants further investigation.

Keyphrases

preterm birth
gestational age
pregnancy outcomes
birth weight
pregnant women
chemotherapy induced
low birth weight
blood pressure
weight gain
preterm infants